The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

EU regulator supports a label expansion of Novo Nordisk’s diabetes drug to reflect its potential to lower the risk of ...

XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the label of its diabetes drug Ozempic, the Danish drugmaker said in a ...

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...

Learn how kidney stones form, their risk factors, and effective treatments. Expert tips on prevention and management.

Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

ANSWER: There is at least one long-term danger I know from the long-term use of acetaminophen (Tylenol), and it is kidney ...

A young lady and potential music sensation, Kehinde Onilewura has made a passionate appeal to governments, corporate bodies, ...

I am a 73-year-old man who has recently been diagnosed with moderate-to-severe arthritis in my right knee. I am trying to figure out a healthy way to manage ...